title: Granulomatous slack skin with extracutaneous involvement and a good response to bortezomib-based chemotherapy.
authors.affiliation: Department of Dermatology.
authors.forename: Yue-ping
authors.initials: YP
authors.lastname: Zeng
authors.forename: Jian
authors.initials: J
authors.lastname: Li
authors.forename: Ding-rong
authors.initials: DR
authors.lastname: Zhong
authors.forename: Hong-zhong
authors.initials: HZ
authors.lastname: Jin
authors.forename: Qiu-ning
authors.initials: QN
authors.lastname: Sun
authors.forename: Kai
authors.initials: K
authors.lastname: Fang
authors.forename: Jun
authors.initials: J
authors.lastname: Li
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001365:Axilla; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D007264:Inguinal Canal; D008198:Lymph Nodes / Q000473:pathology*; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D000093542:Gemcitabine
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D003841:Deoxycytidine; D000069286:Bortezomib; D003907:Dexamethasone; D000093542:Gemcitabine